These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

254 related articles for article (PubMed ID: 29914292)

  • 61. A systematic review of genetic variation within nicotinic acetylcholine receptor genes and cigarette smoking cessation.
    Jones SK; Wolf BJ; Froeliger B; Wallace K; Carpenter MJ; Alberg AJ
    Drug Alcohol Depend; 2022 Oct; 239():109596. PubMed ID: 35981468
    [TBL] [Abstract][Full Text] [Related]  

  • 62. CYP2A6 slow nicotine metabolism is associated with increased quitting by adolescent smokers.
    Chenoweth MJ; O'Loughlin J; Sylvestre MP; Tyndale RF
    Pharmacogenet Genomics; 2013 Apr; 23(4):232-5. PubMed ID: 23462429
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Nicotine Dependence, Nicotine Metabolism, and the Extent of Compensation in Response to Reduced Nicotine Content Cigarettes.
    Bandiera FC; Ross KC; Taghavi S; Delucchi K; Tyndale RF; Benowitz NL
    Nicotine Tob Res; 2015 Sep; 17(9):1167-72. PubMed ID: 25555385
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers.
    Chenoweth MJ; Novalen M; Hawk LW; Schnoll RA; George TP; Cinciripini PM; Lerman C; Tyndale RF
    Cancer Epidemiol Biomarkers Prev; 2014 Sep; 23(9):1773-82. PubMed ID: 25012994
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Variants in the CHRNA5-CHRNA3-CHRNB4 Region of Chromosome 15 Predict Gastrointestinal Adverse Events in the Transdisciplinary Tobacco Use Research Center Smoking Cessation Trial.
    Culverhouse RC; Chen LS; Saccone NL; Ma Y; Piper ME; Baker TB; Bierut LJ
    Nicotine Tob Res; 2020 Feb; 22(2):248-255. PubMed ID: 30882151
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Implications of CYP2A6 genetic variation for smoking behaviors and nicotine dependence.
    Malaiyandi V; Sellers EM; Tyndale RF
    Clin Pharmacol Ther; 2005 Mar; 77(3):145-58. PubMed ID: 15735609
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Why do young women smoke? VII COMT as a risk modifying gene for Nicotine dependence - role of gene-gene interaction, personality, and environmental factors.
    Greenbaum L; Kanyas KS; Rigbi A; Alkelai A; Kohn Y; Lerer B
    Hum Psychopharmacol; 2010 Nov; 25(7-8):536-42. PubMed ID: 21312287
    [TBL] [Abstract][Full Text] [Related]  

  • 68. CHRNA5-A3-B4 and DRD2 Genes and Smoking Cessation Throughout Adulthood: A Longitudinal Study of Women.
    Jones SK; Alberg AJ; Wallace K; Froeliger B; Carpenter MJ; Wolf BJ
    Nicotine Tob Res; 2023 May; 25(6):1164-1173. PubMed ID: 36794842
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The Value of Biosamples in Smoking Cessation Trials: A Review of Genetic, Metabolomic, and Epigenetic Findings.
    Saccone NL; Baurley JW; Bergen AW; David SP; Elliott HR; Foreman MG; Kaprio J; Piasecki TM; Relton CL; Zawertailo L; Bierut LJ; Tyndale RF; Chen LS;
    Nicotine Tob Res; 2018 Mar; 20(4):403-413. PubMed ID: 28472521
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials.
    King DP; Paciga S; Pickering E; Benowitz NL; Bierut LJ; Conti DV; Kaprio J; Lerman C; Park PW
    Neuropsychopharmacology; 2012 Feb; 37(3):641-50. PubMed ID: 22048466
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Molecular mechanisms underlying behaviors related to nicotine addiction.
    Picciotto MR; Kenny PJ
    Cold Spring Harb Perspect Med; 2013 Jan; 3(1):a012112. PubMed ID: 23143843
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Pharmacogenetics and nicotine addiction treatment.
    Munafò MR; Shields AE; Berrettini WH; Patterson F; Lerman C
    Pharmacogenomics; 2005 Apr; 6(3):211-23. PubMed ID: 16013953
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome.
    Leventhal AM; Lee W; Bergen AW; Swan GE; Tyndale RF; Lerman C; Conti DV
    Drug Alcohol Depend; 2014 May; 138():109-17. PubMed ID: 24667010
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Pharmacogenetics and smoking cessation with nicotine replacement therapy.
    Ray R; Schnoll RA; Lerman C
    CNS Drugs; 2007; 21(7):525-33. PubMed ID: 17579497
    [TBL] [Abstract][Full Text] [Related]  

  • 75. CHRNA3 rs1051730 genotype and short-term smoking cessation.
    Munafò MR; Johnstone EC; Walther D; Uhl GR; Murphy MF; Aveyard P
    Nicotine Tob Res; 2011 Oct; 13(10):982-8. PubMed ID: 21690317
    [TBL] [Abstract][Full Text] [Related]  

  • 76. CYP2A6 polymorphisms are associated with nicotine dependence and influence withdrawal symptoms in smoking cessation.
    Kubota T; Nakajima-Taniguchi C; Fukuda T; Funamoto M; Maeda M; Tange E; Ueki R; Kawashima K; Hara H; Fujio Y; Azuma J
    Pharmacogenomics J; 2006; 6(2):115-9. PubMed ID: 16402086
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Genetic variation in CYP2A6 predicts neural reactivity to smoking cues as measured using fMRI.
    Tang DW; Hello B; Mroziewicz M; Fellows LK; Tyndale RF; Dagher A
    Neuroimage; 2012 May; 60(4):2136-43. PubMed ID: 22342802
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Cytochrome P450 2A6 and 2B6 polymorphisms and smoking cessation success in patients treated with varenicline.
    Tomaz PRX; Kajita MS; Santos JR; Scholz J; Abe TO; Gaya PV; Krieger JE; Pereira AC; Santos PCJL
    Eur J Clin Pharmacol; 2019 Nov; 75(11):1541-1545. PubMed ID: 31402421
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Impact of genetic variability in nicotinic acetylcholine receptors on nicotine addiction and smoking cessation treatment.
    Russo P; Cesario A; Rutella S; Veronesi G; Spaggiari L; Galetta D; Margaritora S; Granone P; Greenberg DS
    Curr Med Chem; 2011; 18(1):91-112. PubMed ID: 21110812
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption.
    Bergen AW; Michel M; Nishita D; Krasnow R; Javitz HS; Conneely KN; Lessov-Schlaggar CN; Hops H; Zhu AZ; Baurley JW; McClure JB; Hall SM; Baker TB; Conti DV; Benowitz NL; Lerman C; Tyndale RF; Swan GE;
    PLoS One; 2015; 10(7):e0126113. PubMed ID: 26132489
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.